by Smriti Haria | Jul 13, 2021 | Alzheimer's Disease, Medical Officers
As of 2016, 50 million people worldwide had received a diagnosis of Alzheimer’s Disease (AD) [1]. For this vast number, the neurodegenerative component of the condition is unfortunately not the only significant consequence. Preliminary research had suggested a link... 
by Sophie Gilbert | May 21, 2021 | Alzheimer's Disease, Medical Officers
Current research on Alzheimer’s Disease (AD) suggests that it is the abnormal build-up of proteins like amyloids, which deposit plaques in and around brain cells, that lead to degeneration of cognitive function. Until recently, there was no evidence for any... 
by Smriti Haria | May 20, 2021 | Alzheimer's Disease, IV. Others, Medical Officers, Prescribers
According to the Mayo Clinic, around 5.8 million people over the age of 65 in the United States are diagnosed with Alzheimer’s Disease (AD) [1]. Neurons in the brain atrophy, leading to an impairment in thinking, cognitive and social skills. Additionally, AD is the... 
by Eden Sheinin | Jan 20, 2021 | Alzheimer's Disease, Medical Officers
Alzheimer’s disease (AD) is one of the most prevalent illnesses in the U.S. One in three seniors die due to AD or another dementia, making it the sixth leading cause of death nationally. (1) There are no clinically proven therapies to treat AD. Diagnosis has... 
by Vicky Lu | Jan 9, 2021 | Alzheimer's Disease, Medical Officers, Physical Therapy / Medicine and Rehabilitation, Prescribers
To provide care for Alzheimer’s disease (AD) and other dementia patients, America’s total annual payments are projected to increase from 405 billion dollars in 2020, to more than 1.1 trillion dollars in 2050 (1). While our understanding of this illness has...
Recent Comments